Dubai: Under the patronage of Sheikh Hamdan bin Rashid al Maktoum Award for Medical Sciences, the 8th edition of the UAE Cancer Congress kicks off today, 20th October, at the Intercontinental Hotel, Dubai Festival City.
During the opening ceremony, Dr. Manal Omran Taryam, the CEO of Primary Healthcare of the Dubai Health Authority mentioned that the World Health Organization reports that cancer has become one of the top causes of death worldwide and that nearly 14 million people are annually diagnosed with cancer, with 8.2 million cancer-related fatalities recorded. Yet, the World Health Organization expects a 70% increase in cancer incidence over the next two decades. She further said that, “This event is being held at a time of great challenges in terms of treatment and healthcare services, as we have to face the various diseases indiscriminately attacking all age groups throughout our communities. This imposes a great challenge and responsibility on all scientists and professionals in order to control cancer and its implications.”
She said that in the UAE, and specifically Dubai, we realize the dangers that threaten the future humanity and hinder sustainable development. These threats resulting from cancer and other chronic and communicable diseases constitute a serious challenge to our most precious asset, the human capital. “Dubai Health Authority has built its Developmental Strategy on integrated pillars of heath care, preventive medicine, and treatment. Cancer is no exception to this rule, and the Authority is working continuously to support and develop research efforts in this domain. The Authority regards cancer as top priority, and works with high focus on fighting this fatal disease and limiting its implications on societies.”
Dr. Shaheenah Dawood, the Congress President said that this year, the UAE Cancer Congress will be covering current leading topics on multi-disciplinary cancer treatments including breast, lung, stomach, head & neck, blood and other key areas. This year we have also introduced “Challenge the Expert” session, where all the experts will be put on the spot and answer delegates’ questions, discuss their difficult cases and ultimately gain some insight into how to manage them.
The congress enjoys continued support each year from the industry experts, scientific committee, regional and international organizations and hospitals which have played a key role in the development of the scientific programme. The Dubai Health Authority, the Union for International Cancer Control (UICC) and the Breast Surgery International (BSI) are supporting the congress.
This year the unique feature of the meeting would be much talked about immune-oncology which refers to the body’s natural defence system. Immuno therapies help fighting cancer through use of drugs that target one’s immune system. At UAE Cancer Congress leading experts from UAE and UK will focus on new science and technology used in the development of the next generation of effective and safe immunotherapies.
The event is attended by more than 1700 participants from around the world. The congress will be held under the theme ‘Promoting Excellence in Oncology’ – and includes workshops, plenary sessions, abstract presentations, corporate symposia, an exhibit hall, and networking receptions.
MCI is a global leader in engaging and activating audiences. Since 1987 we have been driving innovation in events and production, meetings, incentives, congresses and association and community management. Through our creative, consulting, analytics, sustainability and digital services, MCI helps multinational companies and internal associations enhance their organizational performance, grow globally, energise communities and drive their business results. MCI is an independently owned company with headquarters in Geneva, Switzerland. Our 1,800 professionals in 60 cities and 32 countries help clients across Europe, the Americas, Asia-Pacific, India, the Middle East and Africa. Find out more at www.mci-group.com.